SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Short Interest Update

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the target of a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 616,003 shares, a drop of 21.2% from the February 12th total of 781,872 shares. Currently, 11.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 80,740 shares, the days-to-cover ratio is presently 7.6 days. Based on an average daily trading volume, of 80,740 shares, the days-to-cover ratio is presently 7.6 days. Currently, 11.8% of the shares of the stock are short sold.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Institutional investors and hedge funds have recently made changes to their positions in the stock. Envestnet Asset Management Inc. purchased a new stake in SPDR S&P Pharmaceuticals ETF during the third quarter worth about $10,732,000. Envestnet Portfolio Solutions Inc. boosted its position in SPDR S&P Pharmaceuticals ETF by 6.7% during the third quarter. Envestnet Portfolio Solutions Inc. now owns 171,930 shares of the company’s stock worth $8,242,000 after purchasing an additional 10,842 shares in the last quarter. Park Avenue Securities LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF during the third quarter worth $485,000. Clark Capital Management Group Inc. acquired a new stake in SPDR S&P Pharmaceuticals ETF in the third quarter valued at $2,248,000. Finally, JPMorgan Chase & Co. grew its holdings in SPDR S&P Pharmaceuticals ETF by 2.5% in the third quarter. JPMorgan Chase & Co. now owns 58,699 shares of the company’s stock valued at $2,814,000 after purchasing an additional 1,441 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Price Performance

Shares of XPH stock opened at $53.78 on Tuesday. The business’s fifty day moving average price is $56.38 and its 200 day moving average price is $52.79. SPDR S&P Pharmaceuticals ETF has a 1-year low of $35.22 and a 1-year high of $58.84. The firm has a market capitalization of $279.66 million, a PE ratio of 14.28 and a beta of 0.60.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.